• Je něco špatně v tomto záznamu ?

Advances in the methodological approach to friction period estimation: A European perspective

P. Hanly, M. Ortega Ortega, A. Pearce, I. Soerjomataram, L. Sharp

. 2020 ; 264 (-) : 113289. [pub] 20200815

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019937

The friction cost approach (FCA) estimates the productivity costs of disease from an employer's perspective but the lack of estimates of friction periods in different countries limits its use. Our aim was to use labour market aggregates to generate two alternative estimates of the friction period for European countries and to apply the FCA to illustrate the impact on cancer-related lost productivity costs. We included thirty countries (EU 27 + the United Kingdom, Switzerland and Norway). Base-case Method 1BC used annual Dutch vacancy stock and flow data (2001-2019) to estimate friction periods for this country. A regression model was employed using Dutch data and country-specific vacancy and unemployment rates to generate country-specific friction period estimates for the other 29 countries. Alternative Method 2ALT used country-specific newly occupied jobs as a proxy vacancy flow variable and vacancy stock data to generate friction period estimates. These were applied, within the FCA, to premature cancer mortality data (from GLOBOCAN2018) for all cancers combined for Western European countries. Costs are in €2018. Method 1BC estimated friction periods in 2018 ranged from 70.8 days for Greece to 145.9 days for the Czech Republic, with a mean duration of 95.3 days. Method 2ALT produced a mean friction period of 80.0 days. On average, across countries, Method 2ALT friction periods were 15.4 days (-18.5%) shorter than Method 1BC estimates. Friction period estimates over the last decade were shorter than those for 2018 reflecting lower vacancy rates. Total cancer premature mortality costs according to FCA Method 1BC amounted to €1.0 billion in 2018 for Western Europe compared to €0.99 billion for Method 2ALT. We developed two alternative - and viable - methods to estimate country-specific friction periods. These approaches will enable researchers to apply the FCA to estimate the productivity cost of diseases across Europe from an employer's perspective.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019937
003      
CZ-PrNML
005      
20210830101538.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.socscimed.2020.113289 $2 doi
035    __
$a (PubMed)32836019
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Hanly, Paul $u School of Business, National College of Ireland, Mayor Street, Dublin 1, Ireland. Electronic address: paul.hanly@ncirl.ie
245    10
$a Advances in the methodological approach to friction period estimation: A European perspective / $c P. Hanly, M. Ortega Ortega, A. Pearce, I. Soerjomataram, L. Sharp
520    9_
$a The friction cost approach (FCA) estimates the productivity costs of disease from an employer's perspective but the lack of estimates of friction periods in different countries limits its use. Our aim was to use labour market aggregates to generate two alternative estimates of the friction period for European countries and to apply the FCA to illustrate the impact on cancer-related lost productivity costs. We included thirty countries (EU 27 + the United Kingdom, Switzerland and Norway). Base-case Method 1BC used annual Dutch vacancy stock and flow data (2001-2019) to estimate friction periods for this country. A regression model was employed using Dutch data and country-specific vacancy and unemployment rates to generate country-specific friction period estimates for the other 29 countries. Alternative Method 2ALT used country-specific newly occupied jobs as a proxy vacancy flow variable and vacancy stock data to generate friction period estimates. These were applied, within the FCA, to premature cancer mortality data (from GLOBOCAN2018) for all cancers combined for Western European countries. Costs are in €2018. Method 1BC estimated friction periods in 2018 ranged from 70.8 days for Greece to 145.9 days for the Czech Republic, with a mean duration of 95.3 days. Method 2ALT produced a mean friction period of 80.0 days. On average, across countries, Method 2ALT friction periods were 15.4 days (-18.5%) shorter than Method 1BC estimates. Friction period estimates over the last decade were shorter than those for 2018 reflecting lower vacancy rates. Total cancer premature mortality costs according to FCA Method 1BC amounted to €1.0 billion in 2018 for Western Europe compared to €0.99 billion for Method 2ALT. We developed two alternative - and viable - methods to estimate country-specific friction periods. These approaches will enable researchers to apply the FCA to estimate the productivity cost of diseases across Europe from an employer's perspective.
650    12
$a osobní újma zaviněná nemocí $7 D017281
650    _2
$a tření $7 D017276
650    12
$a náklady na zdravotní péči $7 D017048
650    _2
$a lidé $7 D006801
651    _2
$a Česká republika $7 D018153
651    _2
$a Evropa $7 D005060
651    _2
$a Řecko $7 D006115
651    _2
$a Norsko $7 D009664
651    _2
$a Švýcarsko $7 D013557
651    _2
$a Spojené království $7 D006113
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ortega Ortega, Marta $u Applied Economics, School of Economics and Business, Complutense University of Madrid, Campus de Somosaguas, 28223, Pozuelo de Alarcón, Madrid, Spain. Electronic address: martao@ucm.es
700    1_
$a Pearce, Alison $u Sydney School of Public Health, The University of Sydney, NSW, 2006, Australia. Electronic address: alison.pearce@sydney.edu.au
700    1_
$a Soerjomataram, Isabelle $u International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon, CEDEX 08, France. Electronic address: Soerjomataraml@iarc.fr
700    1_
$a Sharp, Linda $u Population Health Sciences Institute, Newcastle University Centre for Cancer, Sir James Spence Institute, Royal Victoria Infirmary, Queen Victoria Road, Newcastle Upon Tyne, NE1 4LP, United Kingdom. Electronic address: linda.sharp@ncl.ac.uk
773    0_
$w MED00008691 $t Social science & medicine (1982) $x 1873-5347 $g Roč. 264, č. - (2020), s. 113289
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32836019 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101538 $b ABA008
999    __
$a ok $b bmc $g 1690689 $s 1140383
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 264 $c - $d 113289 $e 20200815 $i 1873-5347 $m Social science & medicine $n Soc Sci Med $x MED00008691
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...